Company news

Resonance Health Ltd news in 2026

Resonance Health Ltd's news releases, calls and decks from 2026, newest first.

View company

Change in Substantial Holding

November 10, 2026

MRI Muscle Endpoint - Product Update

November 10, 2026

Alteration to Notice of Meeting

November 6, 2026

Cleansing Notice

November 6, 2026

Application for quotation of securities - RHT

November 6, 2026

TrialsWest East-Coast Expansion - Executive Appointment

November 3, 2026

Liver Fibrosis Device Webinar Presentation

October 27, 2026

Liver Fibrosis Device Webinar Presentation

October 27, 2026

Investor Presentation Liver Fibrosis Device & Capital Raise

October 26, 2026

Proposed issue of securities - RHT

October 26, 2026

$6.0 Million Placement Oversubscribed

October 26, 2026

Liver Fibrosis Device - EPoC Study Results

October 26, 2026

Trading Halt

October 22, 2026

Notice of Annual General Meeting/Proxy Form

October 20, 2026

Liver Fibrosis Device - Clinical Trial Results - Webinar

October 19, 2026

AGM Date & Director Nomination Closing Date

September 29, 2026

Change in Substantial Holding

September 24, 2026

Global Strategic Alliance & MSA with Image Analysis Group

September 16, 2026

Appendix 4G & Corporate Governance Statement

August 31, 2026

FY26 Full Year Results & Investor Webinar

August 27, 2026

FY26 Full Year Results & FY27 Guidance Investor Presentation

August 27, 2026

Appendix 4E, Full Year Statutory Accounts & Annual Report

August 27, 2026

FY26 Full Year Results Webinar

August 18, 2026

Cessation of Quarterly Reporting

August 11, 2026

Liver Fibrosis Device Progress & FY26 Portfolio Webinar

June 8, 2026

Profit Guidance Upgrade

May 5, 2026

Receipt of R&D Tax Incentive Refund

March 16, 2026

Half Year Results Presentation

February 26, 2026

Half Year Results

February 26, 2026

Half Year Report & Accounts

February 26, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 29, 2026

Decks in 2026